Press Release
Press Release
The global cerebral somatic oximeters market is likely to be driven by the need for dependable monitoring to avoid adverse events and improve patient care and outcomes. North America, Europe and Asia are likely to be key markets.
Modern simultaneous cerebral/somatic oximeters offer a simple and sensitive indicator of ischemic complications. Advanced solutions enable placement of up to four site-specific oxygenation sensors to identify and correct problems before these escalate.
Features include better cerebral monitoring with somatic monitoring, close identification and management of regional oxygenation issues, placement of up to four sensors for noninvasive, real-time blood oxygenation data on key areas, and availability of objective data for use in customizing patient care, among others. Other features include larger screen display for easier viewing, video output to a second, remote monitor for visibility by the broader care team, improved data downloading via USB, enhanced user preferences, and signal strength indicator to better reflect interference.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Modern solutions are designed to noninvasively, directly and continually measure and monitor changes in the approximate regional haemoglobin oxygen saturation in the blood in the brain of an individual. Such solutions are expected to boost the global cerebral somatic oximeters market. The devices may be used on any and all patients for whom there is concern regarding the potential for cerebral oxygen imbalances. These may also be used as an adjunct trend monitor of haemoglobin oxygen saturation of blood in a region of skeletal muscle tissue under the sensor of an individual at risk for decreased-flow or no-flow ischemic states.
In 2021, Medtronic plc announced that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for its INVOS™ 7100 cerebral/somatic oximetry system for children from birth to 18 years of age. The INVOS system picked up key signals to inform time-critical decisions by paediatric clinicians related to hemodynamic management, ventilation, and resuscitation for premature infants, neonates, children, and other patients treated by paediatric clinicians.
In 2020, Masimo announced that O3® Regional Oximetry had attained FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in oxyhemoglobin, hemoglobin, and deoxyhemoglobin in adult brains. With FDA clearance, O3 was indicated for use in cerebral as well as somatic applications, in U.S. as well as CE mark countries, for all patient populations. Such solutions are expected to boost the global cerebral somatic oximeters market.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.